3YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| triapine | [(3-氨基吡啶-2-基)亚甲基氨基]硫脲 | 143621-35-6 |
| Teriflunomide impurity 3 | 4-amino-N-[4-(trifluoromethyl)phenyl]benzamide | 1011244-72-6 |
| PF-3845 | PF 3845 | 1196109-52-0 |
| HLCL-61.HCl | 8-乙基-1,3,4,9-四氢-1-甲基吡喃并[3,4-B]吲哚-1-乙酸 | 109518-47-0 |
| JNJ-42041935 | JNJ 42041935 | 1193383-09-3 |
| TFAP | N-(5-Amino-2-pyridinyl)-4-trifluoromethylbenzamide | 1011244-68-0 |
| BMS-1001 | BMS-1001 | 2113650-03-4 |
| KEA1-97 | KEA1-97 | 2138882-71-8 |
| IKE | IKE | 1801530-11-9 |
| (Rac)-Benpyrine | (Rac)-Benpyrine | 1333714-43-4 |
| BCH001 | 化合物 BCH001 | 384859-58-9 |
| BSJ-4-116 | 化合物BSJ-4-116 | 2519823-34-6 |
| Porcupine-IN-1 | 4-(4-(苄氧基)苄基)哌啶盐酸盐 | 1177093-20-7 |
| SB505124 | SB-505124 | 694433-59-5 |
| brassinazole | 3-(4-氯苯基)-1-甲基-1-苯基-2-(1,2,4-三唑-1-基)-1-丙醇 | 224047-41-0 |
| LY-2090314 | LY 2090314 | 603288-22-8 |
| AL 082D06 | AL 082D06游离态 | 256925-03-8 |
| PCI 29732 | 4-氨基-1-环戊基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-D]嘧啶 | 330786-25-9 |
| AM92016.HCL | N-[4-[3-[[2-(3,4-二氯苯基)乙基]甲基氨基]-2-羟基丙氧基]苯基]甲磺酰胺盐酸盐 | 133229-11-5 |
| CU-242 | 16082-64-7 | 16082-64-7 |
| RAD5-IN-1 | RAD51-IN-17 | 2101739-18-6 |
| MRGPRX1 agonist 1 | MRGPRX1 agonist 1 | 2377379-39-8 |
| GRP-60367.HCl | (4-((2-(2,5-二甲基苯氧基)乙基)氨基)哌啶-1-基)(吡啶-4-基)甲酮 | 1309241-34-6 |
| JBSNF-000088 | 6-甲氧基-3-吡啶羧胺 | 7150-23-4 |
| GR 125,743 | 化合物GR 125743 | 148547-33-5 |
| L-765314 | L-765314 | 189349-50-6 |
| BPTES | BPTES | 314045-39-1 |
| SBC-1107326 | 化合物SBC-110736 | 1629166-02-4 |
| JD5037 | JD-5037 | 1392116-14-1 |
| SR4370 | SR-4370 | 1816294-67-3 |
| RGX-104(HCl) | RGX-104 HCl | 610318-03-1 |
| CK1-IN-1 | CK1-IN-1 | 1784751-20-7 |
| lmptp inhibitor 1 | LMPTP INHIBITOR 1 dihydrochloride | 2310135-46-5 |
| AZ-32 | AZ32 | 2288709-96-4 |
| Elesclomol | 伊利司莫 | 488832-69-5 |
| Bisindolylmaleimide VIII acetate | 3-[1-(3-氨基丙基)-1H-吲哚-3-基]-4-(1-甲基-1H-吲哚-3-基)-1H-吡咯-2,5-二酮单乙酸盐 | 138516-31-1 |
| SJ-172550 | CS-1226 | 431979-47-4 |
| Roflumilast N-oxide | 罗氟司特N-氧化物 | 292135-78-5 |
| AMG487 | AMG 487 | 473719-41-4 |
| TM5275 Na | CS-2524 | 1103926-82-4 |
| JNJ-18038683 | 化合物JNJ-18038683 | 851376-05-1 |
| adenosine amine congener | ADENOSINE AMINE CONGENER | 96760-69-9 |
| Enpp-1-IN-1 | Enpp-1-IN-1 | 2289728-58-9 |
| ROCK inhibitor-2 | ROCK inhibitor-2 | 1127308-52-4 |
| Ro0335 | RO0335 | 867365-76-2 |
| Radiprodil | RADIPRODIL | 496054-87-6 |
| Practolol | 普拉洛尔 | 6673-35-4 |
| AZ304 | AZ304 | 942507-42-8 |
| RGX104free acid | RGX-104 | 610318-54-2 |
| cFMS Receptor Inhibitor II | CFMS RECEPTOR INHIBITOR II | 959860-85-6 |
| ML382 | 2-[(Cyclopropylsulfonyl)amino]-N-(2-ethoxyphenyl)benzamide | 1646499-97-9 |
| CITCO | CITCO | 338404-52-7 |
| Pizuglanstat | 化合物PIZUGLANSTAT | 1244967-98-3 |
| SNDX-5613 | SNDX-5613 | 2169919-21-3 |
| N-(2-BENZO[1,3]DIOXOL-5-YL-ETHYL)-2-(4-METHYL-BENZYL)-SUCCINAMIC ACID | N-(2-BENZO[1,3]DIOXOL-5-YL-ETHYL)-2-(4-METHYL-BENZYL)-SUCCINAMIC ACID | 332849-40-8 |
| Finasteride Carboxaldehyde | (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-二甲基-2-氧代乙基)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-十四氢-4a,6a-二甲基-2-氧代-1H-茚并[5,4-f]喹啉-7-羧酰胺 | 154387-61-8 |
| SB297006 | SB 297006 | 58816-69-6 |
| BIBF-0775 | BIBF0775 | 334951-90-5 |
| LY2584702.TSOH | LY2584702 TOSYLATE | 1082949-68-5 |
| CP671305 | CS-2886 | 445295-04-5 |
| SSD114.HCl | SSD114 | 554428-55-6 |
| SR4370 | 4-QUINOLINECARBOXAMIDE, N-[3-[[[2-[4-(AMINOSULFONYL)PHENYL]ETHYL]AMINO]CARBONYL]PHENYL]-1,2-DIHYDRO-2-OXO- | 939760-13-1 |
| UAMC3203 | UAMC-3203 | 2271358-64-4 |
| Aumitin | AUMITIN | 946293-78-3 |
| Nitrocaramiphenhydrochloride | 化合物NITROCARAMIPHEN HYDROCHLORIDE | 98636-73-8 |
| Sulfopin | Acetamide, 2-chloro-N-(2,2-dimethylpropyl)-N-(tetrahydro-1,1-dioxido-3-thienyl)- | 2451481-08-4 |
| TAK-063 | 1-(2-氟-4-(1H-吡唑-1-基)苯基)-5-甲氧基-3-(1-苯基-1H-吡唑-5-基)哒嗪-4(1H)-酮 | 1238697-26-1 |
| TM5441 | CS-2510 | 1190221-43-2 |
| JMS-17-2 | Pyrrolo[1,2-a]quinoxalin-4(5H)-one,5-[3-[4-(4-chlorophenyl)-1-piperidinyl]propyl]- | 1380392-05-1 |
| SPHINX31 | CS-2837 | 1818389-84-2 |
| Elsulfavirine | Elsulfavirine | 868046-19-9 |
| UAMC3203.HCL | UAMC-3203 HYDROCHLORIDE | 2271358-65-5 |
| AMG510 | AMG510单一构型（R） | 2296729-00-3 |
| Vodobatinib | K0706 | 1388803-90-4 |
| Menin-MLLinhibitor20 | Carbamic acid, N-[(3R)-1-[[2-[[[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]amino]carbonyl]-4-pyridinyl]methyl]-3-piperidinyl]-, 1,1-dimethylethyl ester | 2448173-47-3 |
| SC144 | 吡嗪羧酸 2-(7-氟吡咯并[1,2-A]喹喔啉-4-基)酰肼 | 895158-95-9 |
| Diphenylterazine | DTZ | 344940-63-2 |
| PNU112455A hydrochloride | N4-(6-AMINOPYRIMIDIN-4-YL)-SULFANILAMIDE HCL | 21886-12-4 |
| MCUi4 | MCU I4 | 371924-24-2 |
| VTP50469 | VTP50469 | 2169916-18-9 |
| Pocapavir(SCH-48973; V-073) | SCH 48973 | 146949-21-5 |
| IWR-1-endo | IWR-1 | 1127442-82-3 |
| VU0364770 | VU 0364770 | 61350-00-3 |
| AM-211 | 化合物AM211 | 1175526-27-8 |
| B02 | RAD51 INHIBITOR B02 | 1290541-46-6 |
| alofanib | RPT835 | 1612888-66-0 |
| F-15599 | 635323-95-4 | 635323-95-4 |
| ABT702.HCL | ABT 702 DIHYDROCHLORIDE(二盐酸盐) | 1188890-28-9 |
| AX-024.HCl | AX-024 HYDROCHLORIDE | 1704801-24-0 |
| PS210 | PS 210 | 1221962-86-2 |
| MRTX1133 | MRTX1133 | 2621928-55-8 |
| FOY251 | FOY 251 | 71079-09-9 |
| Merafloxacin | CI 934 | 91188-00-0 |
| SAG | SAG | 912545-86-9 |
| BMS1166 HCl | BMS-1166 HCl | 2113650-05-6 |
| MS402 | MS-402 | 1672684-68-2 |
| C-7280948 | C7280948 | 587850-67-7 |
| Ro 31-8220 mesylate | RO-31-8220 | 138489-18-6 |
| Simufilam | 1-苄基-8-甲基-1,4,8-三氮杂螺[4.5]癸烷-2-酮 | 1224591-33-6 |
| PD169316 | 4-[4-(4-氟苯基)-2-(4-硝基苯基)-1H-咪唑-5-基]吡啶 | 152121-53-4 |
联系方式
